torsemide has been researched along with Chronic Illness in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cicoira, M; Dini, FL; Genta, FT; Ghio, S; Klersy, C; Rossi, A; Scelsi, L; Simioniuc, A; Tavazzi, L; Temporelli, PL | 1 |
| Afanas'ev, SA; Nevdakh, AE; Repin, AN; Rogovskaia, IuB | 1 |
| Arutiunov, GP; Dragunov, DO; Sokolova, AV | 1 |
| Frolkina, MO; Shiriaev, IV; Shtegman, OA | 1 |
| Antonijoan, RM; Ballester, MR; Delgadillo, J; Gich, I; Puntes, M; Roig, E; Santos, B | 1 |
| Bakuła, E; Balsam, P; Cacko, A; Filipiak, KJ; Fojt, A; Grabowski, M; Główczyńska, R; Huczek, Z; Kowalik, R; Markulis, M; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Tymińska, A | 1 |
| Díez, J; González, A; Hermida, N; Laviades, C; López, B | 1 |
| Anguita, M; Castro-Beiras, A; Cobo, E; Coca, A; Conthe, P; de Teresa, E; Díez, J; Fernández, E | 1 |
| Acuña, C | 1 |
| Arystanova, A; Khoseva, EN; Nekrasova, NI; Pataraia, SA; Preobrazhenskiĭ, DV; Talyzina, IV | 1 |
| Cosín, J; Díez, J | 1 |
| Falkenstein, P; Follath, F; Gutzwiller, F; Müller, K; Reitberger, U; Spannheimer, A | 1 |
| Gamba, G; Hess, B; Jaquet, F; Müller, K | 1 |
| Yamamoto, T; Yano, M | 1 |
| Ishido, H; Kamiyama, M; Katogi, T; Kobayashi, T; Kyo, S; Masutani, S; Senzaki, H; Taketazu, M | 1 |
| Medert, G; Wittig, T | 1 |
| Plosker, GL; Young, M | 1 |
| Achhammer, I; Glocke, M; Häcker, W | 1 |
| Delarge, J; Luyckx, AS; Scheen, AJ; Vancrombreucq, JC | 1 |
4 review(s) available for torsemide and Chronic Illness
| Article | Year |
|---|---|
Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide.
Topics: Chronic Disease; Diuretics; Fibrosis; Heart Diseases; Humans; Kidney Diseases; Myocardium; Risk Factors; Sulfonamides; Torsemide | 2008 |
[Update: prolonged-release torasemide].
Topics: Animals; Chronic Disease; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2010 |
[Torasemide is the effective loop diuretic for long-term therapy of arterial hypertension].
Topics: Biological Availability; Blood Pressure; Chronic Disease; Dose-Response Relationship, Drug; Half-Life; Heart Failure; Humans; Hyperglycemia; Hypertension; Hypokalemia; Loop of Henle; Renin-Angiotensin System; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Treatment Outcome | 2011 |
[Aldosterone antagonist therapy for chronic heart failure].
Topics: Aldosterone; Chronic Disease; Death, Sudden, Cardiac; Diuretics; Eplerenone; Fibrosis; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardium; Randomized Controlled Trials as Topic; Spironolactone; Sulfonamides; Torsemide; Ventricular Remodeling | 2005 |
8 trial(s) available for torsemide and Chronic Illness
| Article | Year |
|---|---|
[Effect of loop diuretics with different elimination half-lives on natriuresis changes and indicators characterizing the state of renal tubulointerstitial tissue].
Topics: Adult; Angiotensin II; Chronic Disease; Delayed-Action Preparations; Female; Half-Life; Heart Failure; Humans; Hypertension; Kidney Tubules; Male; Middle Aged; Natriuresis; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2014 |
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Chronic Disease; Cross-Over Studies; Delayed-Action Preparations; Furosemide; Heart Failure; Humans; Middle Aged; Natriuresis; Sodium Potassium Chloride Symporter Inhibitors; Spain; Sulfonamides; Time Factors; Torsemide; Treatment Outcome; Urination | 2015 |
The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Topics: Biomarkers; Chronic Disease; Clinical Protocols; Echocardiography; Electrocardiography, Ambulatory; Furosemide; Heart Failure; Hemodynamics; Humans; Neurotransmitter Agents; Poland; Quality of Life; Recovery of Function; Research Design; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Surveys and Questionnaires; Time Factors; Torsemide; Treatment Outcome; Ventricular Remodeling; Walk Test | 2017 |
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
Topics: Chronic Disease; Collagen Type I; Delayed-Action Preparations; Diuretics; Female; Fibrosis; Furosemide; Heart Failure; Humans; Male; Peptide Fragments; Procollagen; Prospective Studies; Research Design; Sulfonamides; Torsemide | 2009 |
Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
Topics: Aged; Biomarkers; Chronic Disease; Delayed-Action Preparations; Diuretics; Endpoint Determination; Female; Fibrosis; Furosemide; Heart Failure; Humans; Hypertension; Male; Myocardium; Peptide Fragments; Procollagen; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome | 2011 |
Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Quality of Life; Sulfonamides; Torsemide; Treatment Outcome | 2003 |
Efficacy and safety of torasemide in patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Chronic Disease; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Pulse; Random Allocation; Sulfonamides; Torsemide; Water-Electrolyte Balance | 1988 |
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Topics: Aged; Calcium; Chronic Disease; Creatinine; Diuretics; Double-Blind Method; Drug Evaluation; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Osmolar Concentration; Phosphates; Random Allocation; Sulfonamides; Torsemide; Urine | 1986 |
10 other study(ies) available for torsemide and Chronic Illness
| Article | Year |
|---|---|
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Propensity Score; Renal Insufficiency, Chronic; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Ventricular Dysfunction, Left; Young Adult | 2013 |
[Influence of the long-term administration of torasemide on morphometric characteristics of cardiac muscle under conditions of developed experimental postinfarction cardiosclerosis].
Topics: Animals; Antihypertensive Agents; Chronic Disease; Disease Models, Animal; Drug Administration Schedule; Endocardium; Endomyocardial Fibrosis; Heart Failure; Histocytochemistry; Myocardium; Rats; Rats, Wistar; Sulfonamides; Torsemide; Treatment Failure | 2013 |
[Test with torasemide in the differential diagnosis of dyspnea in patients with cardiovascular diseases].
Topics: Adult; Aged; Chronic Disease; Diagnosis, Differential; Diuretics; Dyspnea; Echocardiography, Doppler; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Torsemide | 2014 |
Torasemide in chronic heart failure: results of the TORIC study.
Topics: Aged; Chronic Disease; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Potassium; Product Surveillance, Postmarketing; Stroke Volume; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome; Ventricular Function, Left | 2002 |
[Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cost-Benefit Analysis; Diuretics; Female; Furosemide; Germany; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Patient Admission; Retrospective Studies; Sulfonamides; Switzerland; Torsemide | 2002 |
[Which loop diuretic for heart failure? For prognosis the choices are not all the same].
Topics: Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Randomized Controlled Trials as Topic; Sulfonamides; Survival Rate; Torsemide | 2002 |
[Diuretics in heart failure. Fewer electrolyte disorders -- better prognosis].
Topics: Chronic Disease; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Prognosis; Sulfonamides; Time Factors; Torsemide | 2003 |
Efficacy and safety of torasemide in children with heart failure.
Topics: Child, Preschool; Chronic Disease; Diuretics; Female; Heart Failure; Humans; Infant; Infant, Newborn; Male; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Prospective Studies; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome | 2008 |
[Torasemide in patients with chronic heart failure. Results of clinical administration in general practice].
Topics: Adult; Aged; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides; Torsemide | 1996 |
Torasemide: a pharmacoeconomic review of its use in chronic heart failure.
Topics: Chronic Disease; Clinical Trials as Topic; Costs and Cost Analysis; Heart Failure; Humans; Sulfonamides; Torsemide | 2001 |